NCT04633954View on ClinicalTrials.gov

Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Subconjunctival HemorrhageCataract Surgery
Interventions
DRUG

Brimonidine Tartrate 0.15% Oph Soln

One drop of Brimonidine Tartrate 0.15% Oph Soln prior to FLACS

Trial Locations (1)

L6Y0P6

Uptown Eye Speicialists, Brampton

All Listed Sponsors
lead

Uptown Eye Specialists

OTHER

NCT04633954 - Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery | Biotech Hunter | Biotech Hunter